The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial

DSpace Repository

The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial

Author: Weller, Johannes; Zeyen, Thomas; Schaefer, Niklas; Schaub, Christina; Potthoff, Anna-Laura; Steinbach, Joachim P.; Hau, Peter; Seidel, Clemens; Goldbrunner, Roland; Tabatabai, Ghazaleh; Vatter, Hartmut; Tzaridis, Theophilos; Schneider, Matthias; Herrlinger, Ulrich
Tübinger Autor(en):
Tabatabai, Ghazaleh
Published in: Journal of Neuro - Oncology (2023), Bd. 164, H. 3, S. 749-755
Verlagsangabe: New York : Springer
Language: English
Full text: http://dx.doi.org/10.1007/s11060-023-04470-9
ISSN: 0167-594X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)